BGLC | tickerfilter.com

Fundamental analysis

31%

Profitability 18%

Dept financing 23%

Liquidity 60%

Performance 40%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1,021.06%

1 Month

620.55%

3 Months

704.28%

6 Months

541.46%

1 Year

321.95%

2 Year

396.32%

Key data

Stock price

$2.63

P/E Ratio

57.46

DAY RANGE

$2.55 - $3.11

EPS

-$0.00

52 WEEK RANGE

$0.21 - $3.49

52 WEEK CHANGE

$307.75

MARKET CAP

7.996 M

YIELD

N/A

SHARES OUTSTANDING

17.968 M

DIVIDEND

$0.00

EX-DIVIDEND DATE

04-07-2025

NEXT EARNINGS DATE

04-15-2025

BETA

0.67

PUBLIC FLOAT

AVERAGE 10 VOLUME

$469,317

AVERAGE 30 VOLUME

$1,363,684

Company detail

CEO: N/A
Region: US
Website: bionexusgenelab.com
Employees: 30
IPO year: 2020

Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

N/A

BGLC - BioNexus Gene Lab Corp